Renal growth and development in mice lacking AT(1A) receptors for angiotensin II

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Oliverio, Michael I ^a   Madsen, Kirsten ^c   Best, Christopher F ^a   Ito, Masaki ^b   Maeda, Nobuyo ^d   Smithies, Oliver ^d   Coffman, Thomas M ^a,e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Gene targeting; Juxtaglomerular apparatus; Kidney; Mesangium; Renin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR APPARATUS; KIDNEY DEVELOPMENT; KIDNEY MASS; MICROSCOPIC ANATOMY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

EID: 0031939768     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Anderson, S., T. Meyer, H. Rennke, and B. Brenner. Control of glomerular hypertension limits renal injury in rats with reduced renal mass. J. Clin. Invest. 76: 612-619, 1985.
2. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
3. Bronson, S., and O. Smithies. Altering mice by homologous recombination using embryonic stem cells. J. Biol. Chem. 269: 27155-27158, 1994.
4. Campbell, W., F. Gahnem, D. Catanzaro, G. James, M. Camargo, J. Laragh, and J. Sealey. Plasma and renal prorenin/ renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension 27: 1121-1133, 1996.
5. Chen, X., W. Li, H. Yoshida, S. Tsuchida, F. Takemoto, S. Okubo, A. Fogo, T. Matsusaka, and I. Ichikawa. Gene targeting of angiotensin type 1A (AT1A) or 1B (AT1B) receptor alone does not produce phenotype comparable to angiotensinogen (Atg) gene targeting (Abstract). J. Am. Soc. Nephrol. 7: 1630, 1996.
6. Esther, C., T. Howard, E. Marino, J. Goddard, M. Capecchi, and K. Bernstein. Mice lacking angiotensin converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab. Invest. 74: 953-965, 1996.
7. Friberg, P., B. Sundelin, S.-O. Bohman, A. Bobik, H. Nilsson, A. Wickman, H. Gustafsson, J. Petersen, and M. Adams. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 45: 485-492, 1994.
8. Gomez, R., L. Cassis, K. Lynch, R. Chevalier, N. Wilfong, R. Carey, and M. Peach. Fetal expression of the angiotensinogen gene. Endocrinology 123: 2298-2302, 1988.
9. Gomez, R., K. Lynch, R. Chevalier, N. Wilfong, A. Everett, R. Carey, and M. Peach. Renin and angiotensinogen gene expression in maturing rat kidney. Am. J. Physiol. 254 (Renal Fluid Electrolyte Physiol. 23): F582-F587, 1988.
10. Grady, E., L. Sechi, C. Griffin, M. Schambelan, and J. Kalinyak. Expression of AT2 receptors in the developing rat fetus. J. Clin. Invest. 88: 921-933, 1991.
11. Grone, H.-J., M. Simon, and E. Fuchs. Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F326-F331, 1992.
12. Hein, L., G. Barsh, R. Pratt, V. Dzau, and B. Kobilka. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 377: 744-747, 1995.
13. Ichikawa, I., and R. Harris. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int. 40: 583-596, 1991.
14. Ichiki, T., P. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995.
15. A receptor for angiotensin II. Proc. Natl. Acad. Sci. USA 92: 3521-3525, 1995.
16. Jeunemaitre, X., F. Soubrier, Y. Kotelevtsev, R. Lifton, C. Williams, A. Charru, S. Hunt, P. Hopkins, R. Williams, J.-M. Lalouel, and P. Corvol. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992.
17. Jones, C., C. Sigmund, R. McGowan, C. Kaqne-Haas, and K. Gross. Expression of murine renin genes during fetal development. Mol. Endocrinol. 4: 375-383, 1990.
18. Kakuchi, J., T. Ichiki, S. Kiyama, B. Hogan, A, Fogo, T. Inagami, and I. Ichikawa. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int. 47: 140-147, 1995.
19. Kim, H., J. Krege, K. Kluckman, J. Hagaman, J. Hodgin, C. Best, J. Jennette, T. Coffman, N. Maeda, and O. Smithies. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 92: 2735-2739, 1995.
20. Kitami, Y., T. Okura, K. Marumoto, R. Wakamiya, and K. Hiwada. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem. Biophys. Res. Commun. 188: 446-452, 1992.
21. Krege, J., S. John, L. Langenbach, J. Hodgin, J. Hagaman, E. Bachman, J. Jennette, D. O'Brien, and O. Smithies. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375: 146-149, 1995.
22. Labarca, C., and K. Paigen. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352, 1980.
23. Lafayette, R., G. Mayer, S. Park, and T. Meyer. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90: 766-771, 1992.
24. Llorens-Cortes, C., B. Greenberg, H. Huang, and P. Corvol. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24: 538-548, 1994.
25. Markham, R., J. Sutherland, and M. Mardiney. The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice. Lab. Invest. 29: 111-120, 1973.
26. Marrero, M., B. Schieffer, W. Paxton, L. Heerdt, B. Berk, P. Delafontaine, and K. Bernstein. Direct stimulation of Jak/ STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250, 1995.
27. Matsusaka, T., H. Nishimura, H. Utsunomiya, J. Kakuchi, F. Niimura, T. Inagami, A. Fogo, and I. Ichikawa. Chimeric mice carrying "regional" targeted deletion of the angiotensin type 1A receptor gene: evidence against the role for local angiotensin in the In vivo feedback regulation of renin synthesis in juxtaglomerular cells. J. Clin. Invest. 98: 1867-1877, 1996.
28. Millan, M., P. Carvallo, S.-I. Izumi, S. Zemel, K. Catt, and G. Aguilera. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244: 1340-2, 1989.
29. Niimura, F., P. Labosky, J. Kakuchi, S. Okubo, H. Yoshida, T. Oikawa, T. Ichiki, A. Naftilan, A. Fogo, T. Inagami, B. Hogan, and I. Ichikawa. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 66: 2947-54, 1995.
30. Oliverio, M., C. Best, K. Madsen, O. Smithies, and T. Coffman. The absence of AT1A receptors for angiotensin II causes abnormal drinking behavior and a urinary concentrating defect (Abstract). J. Am. Soc. Nephrol. 7: 1638, 1996.
31. Owens, G. Control of hypertrophie versus hyperplastic growth of vascular smooth muscle cells. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1755-H1765, 1989.
32. Peach, M. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57: 313-370, 1977.
33. Ray, P., L. Bruggeman, S. Horikoshi, G. Aguilera, and P. Klotman. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 45: 177-184, 1994.
34. Sechi, L., E. Grady, C. Griffin, J. Kalinyak, and M. Schambelan. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F236-F240, 1992.
35. Shotan, A., J. Widerhorn, A. Hurst, and U. Elkayam. Ricks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am. J. Med. 96: 451-456, 1994.
36. Sugaya, T., S. Nishimatsu, K. Tanimoto, E. Takimoto, T. Yamagishi, K. Imamura, S. Goto, K. Imaizumi, Y. Hisada, A. Otsuka, H. Uchida, M. Sugiura, K. Fukuta, A. Fukamizu, and K. Murakami. Angiotensin II type 1A receptor-deficient mice with hypotension and hyperreninemia. J. Biol. Chem. 270: 18719-18722, 1995.
37. Tanimoto, K., F. Sugiyama, Y. Goto, J. Ishida, E. Takimoto, K. Yagami, A. Fukamizu, and K. Murakami. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269: 31334-31337, 1994.
38. Timmermans, P., P. Wong, A. Chiu, W. Herblin, P. Benfield, D. Carini, R. Lee, R. Wexler, J. Saye, and R. Smith. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45: 205-251, 1993.
39. Tufro-McReddie, A., J. Harrison, A. Everett, and R. Gomez. Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J. Clin. Invest. 91: 530-537, 1993.
40. Tufro-McReddie, A., D. Johns, K. Geary, H. Dagli, A. Everett, R. Chevalier, R. Carey, and R. Gomez. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F911-F918, 1994.
41. Tufro-McReddie, A., L. Romano, J. Harris, L. Ferder, and R. Gomez. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F110-F115, 1995.
42. Wallace, K., J. Hook, and M. Bailie. Postnatal development of the renin-angiotensin system in rats. Am. J. Physiol. 238 (Regulatory Integrative Comp. Physiol. 7): R432-R437, 1980.
43. Wolf, G., and E. Neilson. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F768-F777, 1990.
44. Zatz, R., B. Dunn, S. Anderson, H. Rennke, and B. Brenner. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77: 1925-1930, 1986.